Repeated infusions of escalating doses of expanded and activated autologous natural killer cells in minimal residual disease-positive Ph plus acute lymphoblastic leukemia patients. A GIMEMA phase 1 trial

AMERICAN JOURNAL OF HEMATOLOGY(2022)

Cited 0|Views24
No score
Key words
acute lymphoblastic leukemia,natural killer cells,leukemia patients,escalating doses,gimema phase,disease-positive
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined